Digital Commons Network^™

Who Bears The Burden? Racial Disparities In Confirmed Cases Of Covid-19 In The Greater Boston Area, Leija Helling

Massachusetts GIS Day

Documenting racial disparities in the spread of COVID-19 is crucial to bettering public health. In the Boston area, non-white and Black communities are significantly overrepresented in areas of high confirmed COVID-19 prevalence. Areas where high prevalence is clustered (“hot spots”) have disproportionate shares of non-white and Black residents, and the disparities are statistically significant. These results confirm marked COVID-19 racial disparities in Boston.

Optimal Mammography Schedule Estimates Under Varying Disease Burden, Infrastructure Availability, And Other Cause Mortality: A Comparative Analyses Of Six Low- And Middle- Income Countries, Shifali Shifali

Masters Theses

Low-and-middle-income countries (LMICs) have a higher mortality-to-incidence ratio for breast cancer compared to high-income countries (HICs) because of late-stage diagnosis. Mammography screening is recommended for early diagnosis, however, current screening guidelines are only generalized by economic disparities, and are based on extrapolation of data from randomized controlled trials in HICs, which have different disease burdens and all-cause mortality compared to LMICs. Moreover, the infrastructure capacity in LMICs is far below that needed for adopting current screening guidelines. This study analyzes the impact of disease burden, infrastructure availability, and other cause mortality on optimal mammography screening schedules for LMICs. Further, these …

The Incubation Period Of Coronavirus Disease 2019 (Covid-19) From Publicly Reported Confirmed Cases: Estimation And Application, Stephen A. Lauer, Kyra H. Grantz, Qifang Bi, Forest K. Jones, Qulu Zheng, Hannah R. Meredith, Andrew S. Azman, Nicholas G. Reich, Justin Lessler

Biostatistics and Epidemiology Faculty Publications Series

Background:

A novel human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was identified in China in December 2019. There is limited support for many of its key epidemiologic features, including the incubation period for clinical disease (coronavirus disease 2019 [COVID-19]), which has important implications for surveillance and control activities.

Objective:

To estimate the length of the incubation period of COVID-19 and describe its public health implications.

Design:

Pooled analysis of confirmed COVID-19 cases reported between 4 January 2020 and 24 February 2020.

Setting:

News reports and press releases from 50 provinces, regions, and countries outside Wuhan, Hubei province, China. …